NYC Health + Hospitals has published a guide to help hospitals and health systems plan and train for emerging infectious disease threats, and customize their plans specific to their unique clinical, operational and financial needs. “All hospitals must be prepared to identify and isolate a patient presenting with a suspected special pathogen infection (i.e., one that is particularly virulent and requires care processes and personal protective equipment beyond daily infection control practices) and inform internal and external stakeholders,” the guide states. “This document provides high-level planning guidance for a frontline hospital multidisciplinary team … to support planning and training for the provision of initial care to such patients while determining whether and when the patient will be transferred to another facility for further assessment and treatment.” In a recent Readiness Advisory, AHA urged hospitals to become familiar with the U.S. Regional Treatment Network for Ebola and Other Special Pathogens and understand their facility’s designated role as part of the network.

Headline
Pennsylvania has recorded its seventh measles-associated death this year as a statewide outbreak of the virus continues, according to an update Nov. 13 by the…
Headline
The Wisconsin Department of Health Services reported Nov. 5 that an infant died of measles, marking the first measles-associated death in the state since 1990.…
Headline
The New York State Department of Health announced Nov. 2 that a child died of measles amid the state’s ongoing outbreak and is the first known measles…
Headline
There have been 1,398 confirmed cases of measles in Pennsylvania this year, according to data released Oct. 28 by the Pennsylvania Department of Health. Data…
Headline
The Centers for Disease Control and Prevention reported 798 laboratory-confirmed flu-associated hospitalizations for the week ending Oct. 17. The weekly…
Headline
The AHA’s latest social media toolkit for spreading awareness of the flu this fall shares messaging on the availability of the flu vaccine for at-risk,…